Galectin Therapeutics Inc.
Nasdaq GALT · Norcross, GA
Works in GI & liver
Galectin Therapeutics Inc. is a clinical trial sponsor based in Norcross, GA, listed as Nasdaq GALT. It has no active clinical trials as lead sponsor; its trials since 2021 were in GI & liver. Since 2021 it has completed 1 trial and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq GALT
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Galectin Therapeutics Inc
Galectin Therapeutics Inc has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 1 trial and stopped 1 early.
Galectin Therapeutics Inc is based in Norcross, GA and is listed as Nasdaq GALT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Galectin Therapeutics Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-14.
Approve Suite is not affiliated with Galectin Therapeutics Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.